| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |